Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03206437 · ClinicalTrials.gov registry record · NA

Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli

A NA study of Post Traumatic Stress Disorder and Anxiety Disorders, sponsored by Georgetown University.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT03206437: Completed NA study of Post Traumatic Stress Disorder and Anxiety Disorders, sponsored by Georgetown University.

NCT03206437 is a NA study of Post Traumatic Stress Disorder and Anxiety Disorders that has completed, run by Georgetown University. The registered enrollment target is 45 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03206437, a NA study of Post Traumatic Stress Disorder and Anxiety Disorders, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effects of Mindfulness-Based Stress Reduction (MBSR) on physiological reactivity. This study will focus on individuals with anxiety who will participate in an 8-week MBSR class. The investigators will test participants' reactivity to both predictable and unpredictable stimuli before and after the class to understand the physiological changes that may occur after to the intervention. Secondary measures include psychometric instruments and a delay discounting task.

Primary Outcome

This variable will be measured by using the Neutral, Predictable, and Unpredictable (NPU) Threat Test

Interventions

  • BEHAVIORAL Waitlist
  • BEHAVIORAL Mindfulness-Based Stress Reduction

Study Locations (1)

District of Columbia

  • Georgetown University Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2017-06-20
Est. Completion 2022-11-25
Phase NA
Georgetown University

227 total trials

What the finished NCT03206437 record still lists

NCT03206437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (93% lower).

The record links to 7 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Waitlist is the first listed.

NCT03206437 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT03206437 about?

NCT03206437 is a clinical study titled "Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli". This study will evaluate the effects of Mindfulness-Based Stress Reduction (MBSR) on physiological reactivity. This study will focus on individuals with anxiety who will participate in an 8-week MBSR class. The investigators will test participants' reactivity to both predictable and unpredictable st...

What is the current status of trial NCT03206437?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-06-20. Estimated completion is 2022-11-25.

What conditions does trial NCT03206437 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Anxiety Disorders, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder.

What interventions are being tested in trial NCT03206437?

The interventions under investigation include: Waitlist (BEHAVIORAL), Mindfulness-Based Stress Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT03206437?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03206437 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03206437's enrollment target sits among peer trials

45 182nd of 262 higher than 80 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03206437, the US trial registry maintained by the National Library of Medicine. NCT03206437 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.